510(k) · Cleared
ClearedCryo-Touch II
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Myoscience, Inc. · GXH Device, Surgical, Cryogenic
Cleared on Sep 17, 2010 as substantially equivalent to K100447 (Myoscience, Inc., 2010) after a 60-day review. Its family tree reaches back 4 generations to 1978. 9 later devices descend from it.
- Decided
- Sep 17, 2010
- Review
- 60 days
- Class
- Class II
- Product code
- GXH
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 4 generations to K781302 (1978). 9 ancestors in all. 9 later devices descend from it, 2 citing it directly.
- Root · 4 generations backK781302 Neurostat, LloydSpembly Medical, Ltd. · 1978
- 3 generations backK031482 Cryostar System, Comprising: a) Cryostar Console, B) Cryostar 1MM…Cryomedical Instruemts, Ltd. · 2003
- 2 generations backK050272 Cryomedical Instruments Cryo-Pac SystemsCryomedical Instruments, Ltd. · 2005
- 1 generation backK100447 Myoscience Cryo-TouchMyoscience, Inc. · 2010
- This deviceK102021 Cryo-Touch IIMyoscience, Inc. · 2010
- Descendant · cites it directly · 8 of its ownK120415 Cryo-Touch IiiMyoscience, Inc. · 2012
- Descendant · cites it directly · 7 of its ownK123516 Cryo-Touch IVMyoscience, Inc. · 2013 · Recalled
- Descendant · 2 generations on · 6 of its ownK133453 IoveraMyoscience, Inc. · 2014
- Descendant · 3 generations on · 5 of its ownK142866 Myoscience iovera systemMyoscience, Inc. · 2015 · Recalled
- Descendant · 4 generations on · 4 of its ownK161835 iovera systemMyoscience, Inc. · 2017
Showing 5 of 9 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 9 · See all- K120415Cryo-Touch IiiMyoscience, Inc. · 2012 · cites it directly8descendants
- K123516Cryo-Touch IVMyoscience, Inc. · 2013 · cites it directly7descendants
- K133453IoveraMyoscience, Inc. · 2014 · 2 generations on6descendants
- K142866Myoscience iovera systemMyoscience, Inc. · 2015 · 3 generations on5descendants
- K161835iovera systemMyoscience, Inc. · 2017 · 4 generations on4descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −4 | K781302 | Neurostat, Lloyd | Spembly Medical, Ltd. | 1978 | — |
| −3 | K031482 | Cryostar System, Comprising: a) Cryostar Console, B) Cryostar 1MM Cryoprobe… | Cryomedical Instruemts, Ltd. | 2003 | — |
| −2 | K050272 | Cryomedical Instruments Cryo-Pac Systems | Cryomedical Instruments, Ltd. | 2005 | — |
| −1 | K100447 | Myoscience Cryo-Touch | Myoscience, Inc. | 2010 | — |
| 0 (this device) | K102021 | Cryo-Touch II | Myoscience, Inc. | 2010 | — |
| +1 | K120415 | Cryo-Touch Iii | Myoscience, Inc. | 2012 | — |
| +1 | K123516 | Cryo-Touch IV | Myoscience, Inc. | 2013 | 1 |
| +2 | K133453 | Iovera | Myoscience, Inc. | 2014 | — |
| +3 | K142866 | Myoscience iovera system | Myoscience, Inc. | 2015 | 1 |
| +4 | K161835 | iovera system | Myoscience, Inc. | 2017 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1983 | 1 | 0 |
| 1986 | 1 | 0 |
| 2003 | 1 | 0 |
| 2006 | 1 | 0 |
| 2009 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2012 | 1 | 0 |
| 2013 | 1 | 0 |
| 2014 | 1 | 0 |
| 2015 | 1 | 0 |
| 2017 | 1 | 0 |
| 2018 | 1 | 0 |
| 2021 | 1 | 0 |
| 2022 | 1 | 0 |
| 2024 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GXH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GXH device
- #1 K250371 cryoICE cryoXT cryoablation probe (cryoXT)score 13.9 · 17 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K100447 | Myoscience Cryo-TouchSummary page 3…Page 55 +-MyoScience 510(k): Device Modification Cryo-Touch Hi This Device Predicate Device Parameter MyoScience MyoScience Cryo-Touch K100447 Cryo-Touch Il intended Use Identical Destroy tissue through freezing Target Population - Identical Adults Anatomical Sites Ide… | 2010 |
What descends from it? (9)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 32 years and passes through 4 companies; a new generation was cleared every 5.3 years on median.
- None of the 9 ancestors has a recall.
- Of its descendants, K120415 (Myoscience, Inc., 2012) has gone furthest, with 8 descendants of its own.
How does its category compare?
All GXH devicesGXH Device, Surgical, Cryogenic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.
FDA decisions per year · GXH
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GXH
52in 2018
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GXH
No recall names GXH since 2007.
Adverse event reports per year · GXH
5in 2025
MAUDE reports naming product code GXH, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 2 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 1 | — | 0 | 0 |
| 2013 | 1 | — | 0 | 0 |
| 2014 | 2 | — | 0 | 0 |
| 2015 | 1 | — | 0 | 1 |
| 2016 | 0 | — | 0 | 1 |
| 2017 | 1 | — | 0 | 2 |
| 2018 | 3 | 52 | 0 | 14 |
| 2019 | 0 | — | 0 | 6 |
| 2020 | 1 | — | 0 | 4 |
| 2021 | 1 | — | 0 | 6 |
| 2022 | 1 | — | 0 | 3 |
| 2023 | 1 | — | 0 | 4 |
| 2024 | 2 | — | 0 | 2 |
| 2025 | 1 | — | 0 | 5 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The MyoScience Cryo-Touch II is used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain. The Cryo-Touch II is not indicated for treatment of central nervous system tissue.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K102021 · printed Nov 6, 2026
Cite this page
510(k) Report. “K102021: Cryo-Touch II.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K102021
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026